21
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.161
Exchange
XHKG - Hong Kong Exchange
0.074 B
Last period Cash and equivalents ,CNY
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Mabpharm
Company Analysis
2181.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
2181.HK financial analysis by Eyestock methodology
Valuation
2181.HK valuation using historical relative method
Statements
2181.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
2181.HK dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Mabpharm`s Cash and equivalents for the period ended 2024-06-30 are 0.074 B CNY
